Poly(C)-binding protein 1 (PCBP1) mediates housekeeping degradation of mitochondrial antiviral signaling (MAVS)

Cell Research

Volumn 22, Issue 4, 2012, Pages 717-727

  Zhou, Xiang ^a   You, Fuping ^a   Chen, Huihui ^a   Jiang, Zhengfan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

cellular antiviral immunity; MAVS; PCBP1; PCBP2

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; INTERFERON; PCBP1 PROTEIN, HUMAN; PCBP2 PROTEIN, HUMAN; RNA BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VISA PROTEIN, HUMAN;

ARTICLE; CELL STRAIN U937; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HELA CELL; HUMAN; INFECTION; METABOLISM; PROTEIN DEGRADATION; RNA INTERFERENCE; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INFECTION; INTERFERON TYPE I; PROTEOLYSIS; RNA INTERFERENCE; RNA-BINDING PROTEINS; U937 CELLS;

EID: 84859434099     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2011.184     Document Type: Article

References (59)

1. Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 2009; 227:54-65.
2. Wilkins C, Gale M Jr. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010; 22:41-47.
3. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122:669-682.
4. Xu LG, Wang YY, Han KJ, et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 2005; 19:727-740.
5. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6:981-988.
6. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437:1167-1172.
7. Scott I. The role of mitochondria in the mammalian antiviral defense system. Mitochondrion 2010; 10:316-320.
8. Dixit E, Boulant S, Zhang Y, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010; 141:668-681.
9. Clement JF, Meloche S, Servant MJ. The IKK-related kinases: From innate immunity to oncogenesis. Cell Res 2008; 18:889-899.
10. Nakhaei P, Genin P, Civas A, Hiscott J. RIG-I-like receptors: Sensing and responding to RNA virus infection. Semin Immunol 2009; 21:215-222.
11. Yoneyama M, Fujita T. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 2010; 20:4-22.
12. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev 2009; 227:75-86.
13. Seth RB, Sun L, Chen ZJ. Antiviral innate immunity pathways. Cell Res 2006; 16:141-147.
14. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8:559-568.
15. Kumar H, Kawai T, Kato H, et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 2006; 203:1795-1803.
16. Sun Q, Sun L, Liu HH, et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006; 24:633-642.
17. Lin R, Paz S, Hiscott J. Tom70 imports antiviral immunity to the mitochondria. Cell Res 2010; 20:971-973.
18. Ting JP, Duncan JA, Lei Y. How the noninflammasome NLRs function in the innate immune system. Science 2010; 327:286-290.
19. Richards KH, Macdonald A. Putting the brakes on the antiviral response: Negative regulators of type I interferon (IFN) production. Microbes Infect 2011; 13:291-302.
20. Komuro A, Bamming D, Horvath CM. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 2008; 43:350-358.
21. Liu SY, Sanchez DJ, Cheng G. New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 2011; 23:57-64.
22. You F, Sun H, Zhou X, et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 2009; 10:1300-1308.
23. Leffers H, Dejgaard K, Celis JE. Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur J Biochem 1995; 230:447-453.
24. Kiledjian M, Wang X, Liebhaber SA. Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J 1995; 14:4357-4364.
25. Evans JR, Mitchell SA, Spriggs KA, et al. Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 2003; 22:8012-8020.
26. Kim SS, Pandey KK, Choi HS, et al. Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol Pharmacol 2005; 68:729-736.
27. Waggoner SA, Johannes GJ, Liebhaber SA. Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest. J Biol Chem 2009; 284:9039-9049.
28. Servant MJ, Grandvaux N, Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 2002; 64: 985-992.
29. Arimoto K, Takahashi H, Hishiki T, et al. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007; 104:7500-7505.
30. Servant MJ, Grandvaux N, tenOever BR, et al. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J Biol Chem 2003; 278:9441-9447.
31. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity 2011; 34:680-692.
32. Sharma S, Fitzgerald KA. Viral defense: It takes two MAVS to Tango. Cell 2010; 141:570-572.
33. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-820.
34. Moore CB, Ting JP. Regulation of mitochondrial antiviral signaling pathways. Immunity 2008; 28:735-739.
35. Jia Y, Song T, Wei C, et al. Negative regulation of MAVSmediated innate immune response by PSMA7. J Immunol 2009; 183:4241-4248.
36. Zhong B, Zhang L, Lei C, et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 2009; 30:397-407.
37. Makeyev AV, Chkheidze AN, Liebhaber SA. A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J Biol Chem 1999; 274:24849-24857.
38. Ostareck-Lederer A, Ostareck DH, Hentze MW. Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2. Trends Biochem Sci 1998; 23:409-411.
39. Makeyev AV, Liebhaber SA. The poly(C)-binding proteins: A multiplicity of functions and a search for mechanisms. RNA 2002; 8:265-278.
40. Zhu Y, Sun Y, Mao XO, Jin KL, Greenberg DA. Expression of poly(C)-binding proteins is differentially regulated by hypoxia and ischemia in cortical neurons. Neuroscience 2002; 110:191-198.
41. Woolaway K, Asai K, Emili A, Cochrane A. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology 2007; 4:28.
42. Sean P, Nguyen JH, Semler BL. The linker domain of poly(rC) binding protein 2 is a major determinant in poliovirus cap-independent translation. Virology 2008; 378:243-253.
43. Chaudhury A, Chander P, Howe PH. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles. RNA 2010; 16:1449-1462.
44. Huo LR, Shen C, Ju WN, et al. Identification of novel partner proteins of PCBP1. Beijing Da Xue Xue Bao 2009; 41:402-408.
45. Meng Q, Rayala SK, Gururaj AE, et al. Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1. Proc Natl Acad Sci USA 2007; 104:5866-5871.
46. Shi H, Bencze KZ, Stemmler TL, Philpott CC. A cytosolic iron chaperone that delivers iron to ferritin. Science 2008; 320:1207-1210.
47. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 2005; 102:17717-17722.
48. Lin R, Lacoste J, Nakhaei P, et al. Dissociation of a MAVS/ IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 2006; 80:6072-6083.
49. Loo YM, Owen DM, Li K, et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci USA 2006; 103:6001-6006.
50. Cheng G, Zhong J, Chisari FV. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 proteasedependent and -independent mechanisms. Proc Natl Acad Sci USA 2006; 103:8499-8504.
51. Chen Z, Benureau Y, Rijnbrand R, et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 2007; 81:964-976.
52. Yang Y, Liang Y, Qu L, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci USA 2007; 104:7253-7258.
53. Zhong B, Zhang Y, Tan B, et al. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J Immunol 2010; 184:6249-6255.
54. Moore CB, Bergstralh DT, Duncan JA, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008; 451:573-577.
55. Yasukawa K, Oshiumi H, Takeda M, et al. Mitofusin 2 inhibits mitochondrial antiviral signaling. Sci Signal 2009; 2:ra47.
56. Pascual V, Chaussabel D, Banchereau J. A genomic approach to human autoimmune diseases. Annu Rev Immunol 2010; 28:535-571.
57. Trinchieri G. Type I interferon: Friend or foe? J Exp Med 2010; 207:2053-2063.
58. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005; 23:307-336.
59. Sun W, Li Y, Chen L, et al. An endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc Natl Acad Sci USA 2009; 106:8653-8658.